We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Patient perspective and safety of remote monitoring of implantable cardioverter-defibrillators in the Polish Nationwide Multicenter Registry: the Medtronic CareLink network evaluation.
- Authors
Maciąg, Aleksander; Mitkowski, Przemysław; Mazurek, Michał; Kaźmierczak, Jarosław; Nowak, Krzysztof; Grabowski, Marcin; Oręziak, Artur; Kempa, Maciej; Bacior, Bogumiła; Gepner, Katarzyna; Chmielewska-Michalak, Lidia; Lenarczyk, Radosław; Kiedrowicz, Radosław; Fuglewicz, Artur; Cacko, Andrzej; Szwed, Hanna
- Abstract
BACKGROUND: Remote monitoring of cardiovascular implantable electronic devices allows the assessment of system effectiveness, arrhythmia occurrence, and indirectly, clinical changes. Medical interventions can be performed earlier because of a faster transfer of information to the monitoring site, even in the case of asymptomatic arrhythmias or abnormalities in the operation of the system. AIMS: The aim of the study was to assess the effectiveness of remote monitoring of implantable cardioverter-defibrillators and evaluation in an outpatient setting during 12-month follow -up. METHODS: We analyzed 176 patients at 10 sites (men, 84.1%). The mean (SD) age of the patients was 60.7 (12.5) years (range, 20-86 years), and mean (SD) follow -up period was 405 (70) days (range, 131-723 days). RESULTS: A total of 354 outpatient and 514 remote follow -up visits were conducted. Episodes of arrhythmias and device malfunctions were detected with similar frequency in outpatient visits and in remote visits. During the study period, patient sense of safety increased. More patients preferred joined remote and outpatient visits as the optimal healthcare model. As the patient survey showed, the greatest benefit of the CareLink network was fast intervention and an increased sense of safety. CONCLUSIONS: The strategy of remote monitoring appeared to be feasible, safe, and patient friendly, demonstrating that the majority of patients do not require an additional in -person visit within 1 year from the device implantation just to confirm the proper functioning of the implantable cardioverter-defibrillators.
- Subjects
POLAND; ARRHYTHMIA; CLINICAL trials; OUTPATIENT services in hospitals; IMPLANTABLE cardioverter-defibrillators; EVALUATION of medical care; MEDICAL consultation; PATIENT monitoring; PATIENT safety; SURVEYS; TELEMEDICINE; MEDICAL equipment reliability; PATIENTS' attitudes; DESCRIPTIVE statistics; MEDICAL implant registries
- Publication
Polish Heart Journal / Kardiologia Polska, 2020, Vol 78, Issue 11, p1115
- ISSN
0022-9032
- Publication type
Article
- DOI
10.33963/KP.15556